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What is biotechnology? What are its
component technologies?
Biotechnology is any technique that uses living or-
ganisms or substances from such organisms to make or
modify a product, improve plants or animals, or develop
microorganisms for specific uses (Persley and Doyle
1999). It includes the traditional techniques of fermen-
tation, and tissue and cell culture as well as the modern
techniques such as genomics, bioinformatics, transfor-
mation, marker-assisted  breeding, diagnostics, and vac-
cine technology.
Fermentation is the production of cells or their sub-
stances under controlled conditions.
Tissue and cell culture is the production of cells or
tissues from multicellular organisms to produce useful
substances, reactions or whole plants and animals.
Genomics is the molecular characterization of a
species.
Bioinformatics is the assembly of data from
genomics into an accessible form.
Transformation (e.g., synthetic genetic engineering,
application of recombinant DNA technology, production
of GMOs) is the transfer of desirable genes into organ-
isms.
Marker-assisted breeding is the use of molecular
markers to identify and evaluate desirable traits in breed-
ing programs.
Diagnostics is the use of molecular characteriza-
tion to provide more accurate and quicker identification
of pathogens.
Vaccine technology is the use of recombinant DNA
technology to produce better (more specific, safer, longer
shelf life, etc.) vaccines.
PIDS Policy Notes are observations/analyses written by PIDS
researchers on certain policy issues. The treatise is wholistic in ap-
proach and aims to provide useful inputs for decisionmaking.
This Notes is based on PIDS  Discussion  Paper Series No.
2000-17 entitled "Agricultural Biotechnology and Development in the
Philippines: The Need for a Strategic Approach" by the author. The
views expressed are those of the author and do not necessarily reflect
those of PIDS or any of the study's sponsors.2
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World trends in biotechnology:
Some outstanding issues
Traditional biotechnology techniques producing in-
dustrial microbial products like microbial cells, antibiot-
ics, alcohol, organic acids, vaccines, enzymes and the
like have long been developed in the industrialized coun-
tries. However, in the past 15 years or so, industries
based on products of genetic engineering have rapidly
developed, especially for human health. Novel fermenta-
tion systems, for instance, were designed for growing
microorganisms and mammalian cells producing human
therapeutic proteins, novel vaccines, diagnostics, and
others. For agriculture, recombinant vaccines and geneti-
cally modified or transgenic crops have been commer-
cially produced. Noteworthy is the rapid adoption rate of
transgenic crops by farmers, the highest, in fact, by any
agricultural industry standard. In particular, the global
area for transgenic crops grew from 1.7 million has. in
1996 to 39.9 million has. in 1999, out of which about
99 percent is found in the U.S.A. (72%), 17 percent in
Argentina and 10 percent in Canada.
Benefits derived Benefits derived
High adoption rates reflect grower satisfaction with
the products that offer significant benefits, ranging from
more convenient and flexible crop management to higher
productivity or higher net returns per hectare to a safer
environment through a decreased use of chemical pesti-
cides. Collectively, all these benefits contribute to a more
sustainable agriculture (Preview 1999, ISAAA Briefs
1999). For example, consumers benefit from cheaper
products and insect-protected transgenic crops which
stem from grains free from mycotoxins. DNA-based mark-
ers are likewise increasingly used in breeding programs
and the rice genome has recently been molecularly char-
acterized, with the information made freely available to
the scientific community.
Modern biotechnology has enabled scientists to
move genes across species barriers and has allowed the
relatively rapid creation of organisms with traits not pos-
sible with conventional breeding techniques. Traits of
importance, which have been or are being transferred to
crop plants, include insect protection, virus protection,
fungal protection, longer shelf life, higher solids for bet-
ter processing recovery, Vitamin A and high iron content
in rice, new color patterns in cut flowers, Hepatitis B vac-
cine in banana, and others. Since these organisms are
created outside of natural processes, they could be
granted patents. Genes are also granted patents, hence,
there has been a rapid scramble for identifying, isolating
and patenting genes.
Reactions to growing trends Reactions to growing trends
All these have raised health, environmental and
social/ethical issues. Thus, in addition to protection as
intellectual property, genetic engineering and its prod-
ucts are subject to regulation to reduce risks to the envi-
ronment, biodiversity and human health at the R&D stage
and commercialization phase. It is likewise subject to
regulation in accordance with the newly-drafted Cartagena
Protocol on Biosafety, Convention on Biological Diversity
during transboundary movement. Labeling of food derived
from transgenic crops has also become mandatory in
some countries like the United Kingdom and Japan.
Despite these regulations, though, there has been
a growing, almost hysterical, campaign against the pro-
duction and sale of transgenic food crops or genetically
manipulated organisms (GMOs) in the past few years.
This has been spearheaded by Greenpeace and groups
(mostly European) raising doomsday scenario of
transgenic crops ruining the environment, with subse-
quent loss of biodiversity and adverse consequences as
well as of the global control of food production by a hand-
ful of multinational firms. The campaign feeds on the
fear of the unknown and is based mostly on misinforma-
tion, exaggerations or projections from limited scientific
reports. Said campaign also deliberately disregards sci-
entific data and, at times, fosters vandalism of farms
growing transgenic crops. In this regard, European con-
sumers have forced the withdrawal of food products from
transgenic crops from supermarket shelves and have
stopped the labeling of such products.
This consumer backlash against transgenic crop-3
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derived foods can be traced to a perceived breakdown in
the European food/feed regulatory system which had al-
lowed the mad cow disease to threaten human health
and the life of the British beef industry as well as has led
to the dioxin contamination of meat from Belgium. Aside
from their  running battle regarding subsidies to their
farming sectors, North America and the European Union
(EU) have thus made biotechnology a trade issue, with
the EU banning certain transgenic crop products from
the U.S.A. on the pretext of protecting consumer con-
cerns. This, however, could be a protectionist tool for the
European farmer who could hardly compete with the Ameri-
can farmer. On the other hand, although labeling is per-
ceived to give a negative impression on transgenic-de-
rived food, in the case of the United Kingdom, tomato
paste derived from transgenic tomato sold better than
its nontransgenic- derived counterpart due to its lower
price.
A number of prominent scientists including Norman
Borlaug, a Nobel Laureate for spearheading the Green
Revolution, warned that the adoption of an anti-transgenic
crop stand by developing countries could have disastrous
consequences. This is because developing countries with
rapidly growing populations lack the land to expand food
production and the time to develop technologies that could
substantially increase their food production in a shrink-
ing and increasingly degraded land area. Farmers in these
countries also often lack the capital to buy the
agrichemicals to improve soil fertility and to ward off
pests. Adopting an anti-transgenic crop stand, therefore,
would simply keep them away from experiencing the ben-
efits of such new technology-based crop production.
Biotechnology in the Philippines:
Status and developments
The Philippines is currently nowhere near the in-
dustrial and modern biotechnology revolution of the West.
The major biotechnology industry in the Philippines at
present comprises mainly of the traditional large-scale
fermentation industries in beer production, alcohol distil-
lation, monosodium glutamate production, soy sauce and
vinegar production and of small-scale production systems
for animal vaccines, nata de coco, bagoong, basi and
other Philippine fermented products.
While the West has been busy developing commer-
cial applications of modern biotechnology in the past two
decades, the Philippine R&D sector had simply focused
on the development of fermentation-based technologies
for agricultural applications such as production systems
for soil inoculants, biocontrol agents, vaccines, enzymes,
diagnostics and foods/feeds and plant tissue culture. A
major reason, of course, is the underfunding of biotech-
nology R&D in the Philippines, except for projects on en-
zymes and diagnostics; the lack of focus leading to a
funding spread in too many projects; and the inadequacy
of facilities and infrastructure support. In addition, ma-
jority of Philippine researchers lack appropriate skills in
modern biotechnology and fermentation engineering. The
few trained ones are spread among a number of institu-
tions. Only PhilRice has a core staff that can undertake
a modest modern biotechnology program using the key
techniques of gene cloning, transformation and marker-
assisted breeding on rice.
The fermentation-based technologies developed are
also yet to be commercialized despite demonstrations of
effectiveness such as increased yields with soil inocu-
lants substituting for chemical fertilizer or biocontrol
agents substituting for chemical pesticides. On the other
hand, plant tissue culture is a relatively cheaper technol-
ogy to develop. Thus, there are now large-scale plant tis-
sue culture systems for banana planting stock and mod-
est-scale orchid culture operations in the country.
Meanwhile, marker-assisted breeding has only been
started recently on mungbean, rice, mango and coconut.
Transformation of rice and papaya was done by local staff,
sent for training abroad, at the International Rice Research
Institute (IRRI) in Los Baños and at the PhilRice. In the
case of corn, only one instance of a field test of a geneti-
cally-modified corn (Bt corn) has been carried out, dem-
onstrating the effectiveness of the Bt gene in protecting
the corn plant from the Asiatic corn borer, an insect caus-
ing 30-80 percent damage in corn.4
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Regulation of modern biotechnology covers only re-
search and development and is administered by the Na-
tional Committee on Biosafety of the Philippines, a multi-
agency committee coordinated by the Department of
Science and Technology (DOST), and by institutional
biosafety committees. There is no regulation specific to
the commercial production or utilization of biotech prod-
ucts despite the near certainty that some of the corn,
soybean and potato imported from the U.S. may have
been genetically modified. Recently, an Intellectual Prop-
erty Act specifically excluding plant and animals from
patents was passed and a bill on plant variety protection
is currently pending in the Senate and House of Repre-
sentatives.
In the midst of these developments, there is a small
foreign-funded group trying to block the commercial plant-
ing and entry of GMOs in the country. This group has
actively tried to block the field test of Bt corn through a
very effective system of disseminating misinformation.
The result is the passage of a resolution to block the Bt
corn field test by the General Santos City Council and of
resolutions at the House and Senate to investigate the
field test. In addition, a bill was filed at the Senate call-
ing for a ban on GMOs and a trumped-up charge against
the DOST, Department of Agriculture (DA) and the Insti-
tute of Plant Breeding (IPB) in connection with the Bt corn
field test was filed at the Supreme Court, which, how-
ever, dismissed the case. The anti-GMO group appears
to be going around the country campaigning. There are
also reports of priests strongly advising parishioners to
reject Bt corn in their homilies.
The biotechnology policy of the Philippines'
Department of Agriculture
The AFMA provision The AFMA provision
The authors of the Agriculture and Fisheries Mod-
ernization Act (AFMA) of 1997 have fully recognized the
importance of biotechnology in modernizing Philippine ag-
riculture. In fact, Agriculture Secretary Edgardo Angara,
then Chairman of the Agricultural Committee (AGRICOM)
that drafted the AFMA in the Senate, specifically included
the provision in the law which provides that of the P20
billion first-year budget appropriated for the AFMA, 10
percent shall be allocated and disbursed for research
and development. Out of this, 4 percent shall be used to
support the Biotechnology Program. In Rule 83.4 of the
implementing rules and regulations for the AFMA, it is
provided that the total budget for agriculture and fisher-
ies R&D shall be allocated such that at least 20 percent
shall be expended on basic research and not more than
80 percent shall be expended for applied research. It is
provided further that biotechnology is considered as ba-
sic research and as such, the allocation of 4 percent of
the total R&D budget shall be sourced from that portion
allocated for basic research.
Attaining the principles of the AFMA Attaining the principles of the AFMA
using biotechnology using biotechnology
The Department of Agriculture intends to use bio-
technology as one of the tools to attain the following prin-
ciples of the AFMA:
Food security and sustainable agriculture. Develop-
ing crops through genetic engineering and marker-assisted
selection that are tolerant to drought and resistant to
pest and diseases would stabilize yields and ensure pro-
duction. Drought-tolerant crops require less water, thereby
conserving an increasingly diminishing resource. Insect
and disease-resistant crops increase yields per unit area,
thereby giving farmers higher incomes. More importantly,
more people may be fed using the same land area which
in effect will prevent having more land from being har-
nessed for agriculture. This is crucial especially since
the available lands are situated in environmentally-
fragile areas like in the uplands. Insect and disease-
resistant crops likewise increase farm profits by reduc-
ing chemical pesticide use, saving not only on chemical
inputs but also on labor. Early determination of plant sex
using molecular markers will ensure higher yields. Local
production of DNA vaccines will ensure animal health,
providing additional income even for farmers in far-flung
areas. And the use of microorganisms for efficient soil
nutrient management will further increase profitability and5
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prevent fertilizer run-offs, thereby maintaining the integ-
rity of our open water systems.
Promotion of health and food safety. Developing rice
and white corn with added nutritional values like higher
iron content through genetic engineering will ensure bet-
ter nutrition for our people. Another health-promoting
advantage expected from pest-protected crops is the
substantial reduction in pesticide residue and aflatoxin
in vegetables and grains.
The program strategy
To develop modern biotechnology, the Department's
approach and strategy would include:
] Adoption of a program that facilitates rather than
limits the development and application of biotechnology,
particularly modern biotechnology, in Philippine agricul-
ture while ensuring the protection of human health and
the environment as well as the conservation and equi-
table sharing of the benefits of the country's genetic re-
sources.
] Strengthening of the capability of the scientific
community to undertake development and risk assess-
ment of biotechnology products such as GMOs through
an aggressive recruitment of appropriately-trained indi-
viduals, nondegree and degree-oriented training of re-
search staff, and provision of adequate facilities and
operating funds for continuing research in selected insti-
tutions.
] Development and adoption of a transparent
regulatory system for the commercialization of GMOs that
is science- or product-based rather than technology- or
process-based. Considering the limited experience the
world has today in modern biotechnology products, the
regulatory system shall allow for amendments as data
and experience come along. Furthermore, acknowledg-
ing the great variety in the type and innovation process
of biotechnology, the regulatory system shall treat bio-
technology products on a case-to-case basis.
] Promotion of the initiative of the private sector
in the development and commercialization of biotechnol-
ogy products and focusing of the public sector efforts in
areas unattended to such as technologies for resource-
poor farmers.
] Promotion of the wise utilization of Philippine
biodiversity by strengthening existing programs of genetic
conservation, assessment and characterization of bio-
logical diversity, and isolation of potentially-useful genes.
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